This is a prospective data collection study of patients with advanced solid...
Status
Completed
Location
Natera
Start Date
2021-05-28
Trial ID
NCT04761783
A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
PHASE2
This study will look at the recurrence-free survival of microsatellite-stab...
Status
Withdrawn
Location
UF Health Davis Cancer Pavilion and Shands Med Plaza
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
PHASE2
This clinical trial studies whether measuring circulating tumor deoxyribonu...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
PHASE2
The NSABP FC-13 study is being done to determine if using immunotherapies a...